Dec 10 · McLean, VA: Network with investors and see emerging startups pitch live. Register →

Frenelle PBC

Frenelle PBC is developing FRN01, a once-monthly subcutaneous buprenorphine injection for Opioid Use Disorder (OUD), and is backed by Mayo Clinic Ventures.

Jeff Missling, CEO

jmissling@frenellepharma.com

https://www.frenellepharma.com/